Increasing complexity in trials challenges ability to keep costs down, Tufts study says
This article was originally published in Scrip
Executive Summary
Ever-increasing clinical trial complexity is making it extremely difficult for pharma/biotech companies to contain costs, a new compilation of data from 2002-2007 by the US Tufts Center for the Study of Drug Development shows.